Search
Returning search results with filters:
Remove filter for
Issue: Product withdrawal
Remove filter for
Last updated: 2023
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 3 of 3 items.
IDHIFA (enasidenib mesylate) – Market Withdrawal and Continued Access
AlertHealth professional risk communication | 2023-06-08
ISTODAX (romidepsin) – Restricted Access Program
AlertHealth professional risk communication | 2023-03-20
RUZURGI (amifampridine) - Authorization Status
AlertHealth professional risk communication | 2023-01-20